Themis Medicare's Stock Reaches All-Time High, Outperforms Sector by 9.15%
Themis Medicare, a smallcap pharmaceutical company, has reached an all-time high in its stock price on September 20, 2024. It has outperformed the sector by 9.15% and is currently trading at a price 1.61% away from its 52-week high. The stock has shown a strong performance in the past year, showcasing its potential in the pharmaceutical industry.
Themis Medicare, a smallcap pharmaceutical company, has recently reached an all-time high in its stock price on September 20, 2024. The stock has been given a 'Hold' rating by MarketsMOJO, a leading stock market analysis platform.
The company's stock is currently trading at a price that is 1.61% away from its 52-week high of Rs 288. It has also outperformed the sector by 9.15% in today's trading session. This marks a trend reversal for the stock, as it has gained after three consecutive days of falling.
In today's trading, Themis Medicare's stock touched an intraday high of Rs 284.75, which is a significant increase of 10.03%. The stock is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend.
In the past year, Themis Medicare's stock has shown a strong performance, with a growth of 68.93%. In comparison, the Sensex has only grown by 25.81% in the same period. This showcases the company's potential and growth in the pharmaceutical industry.
Themis Medicare is a smallcap company in the pharmaceutical and drugs sector. With its recent surge in stock price and positive performance, it is definitely a company to watch out for in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
